Corner Therapeutics Revenue and Competitors

Boston, MA USA

Location

#8379

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Corner Therapeutics's estimated annual revenue is currently $5.9M per year.(i)
  • Corner Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Corner Therapeutics has 38 Employees.(i)
  • Corner Therapeutics grew their employee count by 31% last year.

Corner Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CofounderReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Chief Financial Officer, Chief Business OfficerReveal Email/Phone
5
VP R&DReveal Email/Phone
6
VP, OperationsReveal Email/Phone
7
Laboratory Operations ManagerReveal Email/Phone
8
Program ManagerReveal Email/Phone
9
Senior Manager, Human Resources & Business AdministrationReveal Email/Phone
10
Scientist|Immuno-OncologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Corner Therapeutics?

Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3841%N/A
#2
$7.6M389%N/A
#3
$15M39-33%N/A
#4
$15M408%N/A
#5
$7.2M413%N/A